دورية أكاديمية

Indications for and outcomes of therapeutic plasma exchange after cardiac transplantation: A single center retrospective study.

التفاصيل البيبلوغرافية
العنوان: Indications for and outcomes of therapeutic plasma exchange after cardiac transplantation: A single center retrospective study.
المؤلفون: Onwuemene, Oluwatoyosi A., Grambow, Steven C., Patel, Chetan B., Mentz, Robert J., Milano, Carmelo A., Rogers, Joseph G., Metjian, Ara D., Arepally, Gowthami M., Ortel, Thomas L.
المصدر: Journal of Clinical Apheresis; Aug2018, Vol. 33 Issue 4, p469-479, 11p
مستخلص: Introduction: Limited data are available describing indications for and outcomes of therapeutic plasma exchange (TPE) in cardiac transplantation. Methods: In a retrospective study of patients who underwent cardiac transplantation at Duke University Medical Center from 2010 to 2014, we reviewed 3 TPE treatment patterns: a Single TPE procedure within 24 h of transplant; Multiple TPE procedures initiated within 24 h of transplant; and 1 or more TPE procedures beginning >24 h post‐transplant. Primary and secondary outcomes were overall survival (OS) and TPE survival (TS), respectively. Results: Of 313 patients meeting study criteria, 109 (35%) underwent TPE. TPE was initiated in 82 patients within 24 h, 40 (37%) receiving a single procedure (Single TPE), and 42 (38%) multiple procedures (Multiple TPE). Twenty‐seven (25%) began TPE >24 h after transplant (Delayed TPE). The most common TPE indication was elevated/positive panel reactive or human leukocyte antigen antibodies (32%). With a median follow‐up of 49 months, the non‐TPE treated and Single TPE cohorts had similar OS (HR 1.08 [CI, 0.54, 2.14], P = .84), while the Multiple and Delayed TPE cohorts had worse OS (HR 2.62 [CI, 1.53, 4.49] and HR 1.98 [CI, 1.02, 3.83], respectively). The Multiple and Delayed TPE cohorts also had worse TS (HR 2.59 [CI, 1.31, 5.14] and HR 3.18 [CI, 1.56, 6.50], respectively). Infection rates did not differ between groups but was independently associated with OS (HR 2.31 [CI, 1.50, 3.54]). Conclusions: TPE is an important therapeutic modality in cardiac transplant patients. Prospective studies are needed to better define TPE's different roles in this patient population. [ABSTRACT FROM AUTHOR]
Copyright of Journal of Clinical Apheresis is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:07332459
DOI:10.1002/jca.21622